LJLACTO*6 Vaginal Suppositories 100,000,000 CFU

LJLACTO 100,000,000 CFU VAGINAL SOFTGEL CAPSULES
Lactobacillus plantarum P 17630

What it is and what it is used for
LJLACTO vaginal softgel capsules are indicated for vaginitis and vulvovaginitis in general, as the lactobacilli contained therein, by implanting and multiplying on the vaginal mucosa, not only restore the balance of the autochthonous bacterial flora but also indirectly antagonize, through competition, the colonization by pathogenic germs.
LJLACTO is therefore used, from fertile age onwards, in the topical treatment of vaginal infections caused by pathogenic germs. Particularly in vaginitis associated with ovarian insufficiency, hypofolliculinic leukorrhea, senile vaginitis, vulvar itching, vaginal dystrophy.
LJLACTO is also used as an adjunct in chemotherapeutic and antibiotic treatment of Trichomonas vaginitis.

What you need to know before taking the medicine
Hypersensitivity to the active substance or to any of the excipients.

Warnings and precautions
The use, especially prolonged, of products for topical use, may give rise to sensitization phenomena and produce undesirable effects. In this case, it is necessary to interrupt the treatment and consult your doctor.

LJLACTO does not replace antibiotic or chemotherapeutic treatment, but represents a useful complement, restoring the physiological conditions of the vaginal environment, especially at the end of specific treatment.

Possible side effects
Like all medicines, LJLACTO can cause side effects, although not everybody gets them.

No side effects related to the use of the medicine have been reported.

Following the instructions in the package leaflet reduces the risk of side effects.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.